Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Donate to Science & Enterprise

Please share Science & Enterprise

Infographic – Biotech Index Q3 Rollercoaster

NBI Year to date 30 Sept 2022

For the year-to-date, as noted in today’s chart, NBI shows a general decline, losing more than one-fifth of its value since January. . . . → Read More: Infographic – Biotech Index Q3 Rollercoaster

Start-Up Developing Efficient RNA Process, Raises $12M

Vials and bottles

A company formed earlier this year is commercializing a more efficient process for making synthetic RNA molecules and raising $12 million in seed funds. . . . → Read More: Start-Up Developing Efficient RNA Process, Raises $12M

Company Formed to Boost Clinical Trial Success Odds

Human machine interface

A pharma/tech industry group is starting a new company to use algorithms for finding gaps in preclinical data that can impair clinical trial progress. . . . → Read More: Company Formed to Boost Clinical Trial Success Odds

Addiction Biotech Using Crowdfunding for Investments

Clock and coins graphic

A start-up enterprise developing treatments for drug and alcohol addiction is raising investment capital with a direct pitch to small investors through a crowdfunding platform. . . . → Read More: Addiction Biotech Using Crowdfunding for Investments

Eye Disease Gene-Therapy Biotech Adds Venture Funds

Monitor eyes

A biotechnology company designing treatments for inherited eye diseases with Crispr gene editing is raising €75 million in venture financing. . . . → Read More: Eye Disease Gene-Therapy Biotech Adds Venture Funds

Cell, mRNA Therapy Biotech Raises $165M in Early Funds

T-cells illustration

A new company, founded by university medical researchers, is developing cell therapies engineered with messenger RNA or mRNA to work inside the body. . . . → Read More: Cell, mRNA Therapy Biotech Raises $165M in Early Funds

Venture to Build Cell, Gene Therapy Businesses

Gene therapy graphic

A joint venture with business development and bio-manufacturing companies aims to build new cell and gene therapy businesses to advance treatments from Mayo Clinic labs. . . . → Read More: Venture to Build Cell, Gene Therapy Businesses

Biotech Business Complex Slated for Colorado

38th Street in Boulder, CO

A developer backed by a life science/real estate joint venture announced plans to create a new campus for biotechnology and related businesses in Boulder, Colorado. . . . → Read More: Biotech Business Complex Slated for Colorado

Synthetic Bio Chemicals Start-Up Gains $5M in Early Funds

Brewer's yeast

A new enterprise using digital and synthetic biology to create sustainable chemicals at industrial scale is raising $5 million in pre-seed round funds. . . . → Read More: Synthetic Bio Chemicals Start-Up Gains $5M in Early Funds

Immune Disease Biotech Acquired in $405M Deal

Human T-cell

A biotechnology developer of treatments for autoimmune disorders with checkpoint receptor proteins is acquired by drug maker Gilead Sciences. . . . → Read More: Immune Disease Biotech Acquired in $405M Deal